M
Micro-Bio (Suzhou)
Probiotics Blend, Probiotics Tablet, Probiotics Capsule, Probiotics Powder - Wecare
About Micro-Bio (Suzhou)
Wecare Probiotics specializes in the research, development, and production of probiotic bacteria powders and solid preparations. The company serves a diverse range of clients including food and beverage manufacturers, animal nutrition providers, and daily chemical product companies. Operating in the health and wellness market, Wecare Probiotics focuses on creating high-quality probiotic strains that promote human health and environmental sustainability. The business model revolves around the production and sale of probiotic products, leveraging patented strains and technologies developed at their Wecare Probiotics Research Institute. Revenue is generated through the sale of these probiotic solutions to various industries, including fermented foods, beverages, and animal nutrition. The company recently expanded its production capabilities with a new facility in Suzhou, capable of producing 200 tons of probiotics powder annually, marking a significant step in their growth and commitment to innovation.
Source: Dealroom company dataAt a glance
- Status
- Operational
- Founded
- 2013
- Headquarters
- Suzhou Shi, China
- Employees
- 67
- Open positions
- None listed
- Dealroom signal
- 52.9/100
- Industry
- Health, Food
- Sub-industry
- BioTechnology
- Sector
- Biotech & Life Sciences, Biotechnology, Biotech and Pharma, Hard Tech
- Business model
- Manufacturing
- Client focus
- b2c
Knowledge graph
More headlines
Funding history
Company financing events and reported valuations.
| Deal type | Date | Amount | Valuation | Investors | Source |
|---|---|---|---|---|---|
| SERIES D✓Equity / VC | Jul 2024 | — | — | Suzhou International Development Venture Capital Holding · China Merchants Capital · SDIC Unity Capital | ↗ |
| SERIES DEquity / VC | Oct 2023 | $0 | — | Qiming Venture Partners | — |
Growth signals
Latest recorded traffic for Micro-Bio (Suzhou) is 1.8K monthly website visits, up 63.6% over the last three months. Micro-Bio (Suzhou)'s team grew 13.6% over the past year.
Similar companies
Company identity and context are open; selected comparison metrics preview what is available on the platform.
Investments and acquisitions
Recent portfolio relationships for companies that also act as investors or acquirers.
Investors
From Dealroom's funding and investor records, grouped by the round each investor first entered.
Series A1 investor entered at this stage
- HCHairong Capital
Series B and later7 investors entered at this stage
- TCTaifu Capital
- DCDongyun Venture Capital
Boyuan Capital
Qiming Venture Partners
Suzhou International Development Venture Capital Holding- CCChina Merchants Capital
SDIC Unity Capital
Other known investors1 additional known investor
TF Capital
Source: Dealroom Talent Intelligence.
Global footprint
team presence
Market sentiment
An AI-synthesised read of the highest-engagement posts about Micro-Bio (Suzhou) on X, ranked by likes and reposts, corporate channels excluded.
Reading the room on X — pulling top posts and synthesizing themes…
Source: X recent search ranked by engagement (likes + retweets) · Synthesis by Claude · Cached for 1 hour
See Micro-Bio (Suzhou)’s full profile on Dealroom
Request a free trial to see the complete deal history, financials, people graph and growth signals.
Takes under a minute. Already use Dealroom? Log in.